The Role of Primary Health Care to Follow up Women With Cervical - - PowerPoint PPT Presentation

▶

Jan 26, 2024 163 likes •197 views

ROP25 Federal University of Rio Grande do Sul Faculty of Medicine Post-Graduate Program of Epidemiology The Role of Primary Health Care to Follow up Women With Cervical Cancer Precursor Lesions Wilhelms D.M., Bozzetti M.C. , Flores R. Objective

SLIDE 1

The Role of Primary Health Care to Follow up Women With Cervical Cancer Precursor Lesions

Wilhelms D.M., Bozzetti M.C., Flores R.

Federal University of Rio Grande do Sul Faculty of Medicine Post-Graduate Program of Epidemiology

Objective To evaluate the screening program developed in Primary Care Services (PCS), especially regarding the follow-up of positive cases identified during screening. Methods

Historical cohort
Women attending PCS, in Southern Brazil.
Inclusion Criteria: all women who presented precursor lesions of cervical cancer

in the PAP smear, between 2001 and 2007 were enrolled and followed up to 2011.

Previous cervical screening history, diagnosis/treatment, and follow-up were

evaluated.

ROP25

SLIDE 2

Methods

Fase 1

– Analysis of all PAPs collected between 2001 and 2007 to select those showing precursor lesions;

Focus on screening by age, specimen adequacy (satisfactory vs

unsatisfactory) and percent of abnormal exams.

Fase 2

– Screening analysis; – Diagnostic and treatment analysis; – Follow-up (to the year 2011) of women with precursor lesions Inclusion criterium – women with the following cytological results: ASC-H, HSIL or Carcinoma (Squamous/Adeno), identified between 2001 and 2007. Exclusion criterium - women with the following cytological results:HSIL

r Carcinoma (Squamous/Adeno), before the year 2001.

ROP25

SLIDE 3

Study Sample
Results:

46018 cytologic exams 2001 to 2007

ASC-US LSIL HSIL ASC-H AGUS Carcinoma (Ca) 1626 (63%) 775 (30%) 119 (4.6%) 11 (0.43%) 41 (1.6%) 10 (0.38%)

Studied population = 134 women 78 CIN II 58% 36 CIN III 27% 11 ASC-H 8% 9 Ca 7% 114 (85%)

ROP25

Previous screening (n/%) ASC-H CIN II CIN III Carcinoma NO 3(5%) 23(45%) 17(33%) 8(16%) YES 8(10%) 55(66%) 19(23%) 1(1%) ! Referred to gynecologist 10(91%) 74(95%) 33(92%) 9(100%) ! Attended Appointment 9(90%) 72(97%) 33(100%) 8(89%) ! Histology performed 9(100%) 65(90%) 32(97%) 8(100%) ! Diagnosis confirmation 4(44%) 48(74%) 31(97%) 8(100%)